The FDA is monitoring the possibility that the Johnson and Johnson’s COVID-19 vaccine could be linked to an increased risk of developing Guillain-Barré Syndrome.
Fuente: Youtube
The FDA is monitoring the possibility that the Johnson and Johnson’s COVID-19 vaccine could be linked to an increased risk of developing Guillain-Barré Syndrome.
Fuente: Youtube